GFAP-IL6 mice exhibit signs of disease such as impaired hippocampal long-term potentiation [9, 10], neuronal hyperexcitability [10, 11], progressive cognitive decline [12] and development of ataxia [2, 8]. The gene discussed is GFAP; the disease is Ataxia.